Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shu Tang Granules in Type 2 Diabetes (Qi-Yin Deficiency with Liver Qi Stagnation)
CTR20150692Phase 2Active
- Sponsor
- Hebei Zhongtang Pharmaceutical
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Shutang granules in type 2 diabetes mellitus (T2DM), sponsored by Hebei Zhongtang Pharmaceutical. Started Nov 2015; status: active.
02
Drugs
Shutang granules
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20150692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150692.